Find research datasets worth reusing
Search datasets from major research repositories and use ShareScore to quickly assess how well each record supports discovery, access, and reuse.
67
datasets available to search
ShareScore release 0.9.0
Dataset results
67 results for “cediranib”
Efficacy and Safety Study of Cediranib in Combination With Olaparib in Patients With Recurrent Platinum-Resistant Ovarian Cancer
ClinicalTrials.gov study NCT02889900. IPD Sharing: YES. Countries: 1. Publications: 0.
Testing the Combination of the Study Drugs Cediranib and Olaparib in Recurrent Ovarian Cancer
ClinicalTrials.gov study NCT02345265. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Docetaxel and Prednisone With or Without Cediranib in Treating Patients With Metastatic Prostate Cancer That Did Not Respond to Hormone Therapy
ClinicalTrials.gov study NCT00527124. IPD Sharing: Not stated. Countries: 1. Publications: 0.
A Phase I/II Study of Cediranib (AZD2171) in Japanese Metastatic Colorectal Cancer Patients in Combination With FOLFOX
ClinicalTrials.gov study NCT00494221. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Cediranib Maleate in Treating Patients With Recurrent or Metastatic Kidney Cancer That Cannot Be Removed By Surgery
ClinicalTrials.gov study NCT00227760. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Phase I Safety and Tolerability Study of Cediranib (RECENTIN™, AZD2171) in Combination With Chemo in First Line Lung Cancer Patients
ClinicalTrials.gov study NCT00621361. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Durvalumab (MEDI4736) Plus Cediranib in Patients With Metastatic Uveal Melanoma
ClinicalTrials.gov study NCT04184518. IPD Sharing: UNDECIDED. Countries: 1. Publications: 0.
A Phase II Clinical Trial of Cediranib and Olaparib Maintenance in Advanced Recurrent Cervical Cancer
ClinicalTrials.gov study NCT04487587. IPD Sharing: NO. Countries: 1. Publications: 0.
Phase 1 Study of the Effect of Ketoconazole on the PK of Multiple Doses of Cediranib in Patients With Solid Tumours
ClinicalTrials.gov study NCT00750425. IPD Sharing: Not stated. Countries: 2. Publications: 0.
Phase I : Cediranib in Combination With Lomustine Chemotherapy in Recurrent Malignant Brain Tumour
ClinicalTrials.gov study NCT00503204. IPD Sharing: Not stated. Countries: 2. Publications: 0.
Cediranib Maleate in Treating Patients With Recurrent or Newly Diagnosed Metastatic Head and Neck Cancer
ClinicalTrials.gov study NCT00458978. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Cediranib Maleate and Whole Brain Radiation Therapy in Patients With Brain Metastases From Non-Small Cell Lung Cancer
ClinicalTrials.gov study NCT00937482. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Study of Cediranib Plus Cisplatin Plus Capecitabine/S-1 in Japanese Gastric Cancer Patients
ClinicalTrials.gov study NCT00960349. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Cediranib Maleate in Treating Patients With Locally Advanced or Metastatic Liver Cancer
ClinicalTrials.gov study NCT00238394. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Olaparib With Cediranib or AZD6738 for the Treatment of Advanced or Metastatic Germline BRCA Mutated Breast Cancer
ClinicalTrials.gov study NCT04090567. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Kidney and Blood Pressure Changes in Patients Receiving Bevacizumab, Aflibercept, Sunitinib, or Cediranib for Cancer
ClinicalTrials.gov study NCT00691730. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Cediranib as Palliative Treatment in Patients With Symptomatic Malignant Ascites or Pleural Effusion
ClinicalTrials.gov study NCT01262612. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Bevacizumab and Cediranib Maleate in Treating Patients With Metastatic or Unresectable Solid Tumor, Lymphoma, Intracranial Glioblastoma, Gliosarcoma or Anaplastic Astrocytoma
ClinicalTrials.gov study NCT00458731. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Carboplatin and Paclitaxel With or Without Cediranib Maleate in Treating Patients With Metastatic or Recurrent Cervical Cancer That Cannot Be Removed by Surgery
ClinicalTrials.gov study NCT01229930. IPD Sharing: Not stated. Countries: 1. Publications: 0.
A Study of Cediranib and Olaparib at the Time Ovarian Cancer Worsens on Olaparib
ClinicalTrials.gov study NCT02340611. IPD Sharing: Not stated. Countries: 1. Publications: 0.
ScienceDex guides
Understand access before you commit
These curated guides explain access requirements, typical timelines, costs, and reuse considerations for widely used research datasets.
Allen Brain Atlas
Allen Brain Atlas is an Allen Institute collection of brain map atlases, datasets, APIs, and analysis tools covering mouse, human, and non-human primate brain resources.
Annotated Behaviour and Observability Dataset (ABODe)
ABODe is a University of Edinburgh DataShare dataset for behavior classification in group-housed mice using home-cage video, identities, bounding boxes, ground-plate positions, and annotator labels.
DANDI Archive for NWB datasets
DANDI is a BRAIN Initiative archive for publishing and sharing neurophysiology data, including electrophysiology, optophysiology, and behavioral data packaged as NWB and related standards.
International Brain Laboratory public data
The International Brain Laboratory public data releases expose standardized mouse decision-making experiments, including Neuropixels recordings, widefield calcium imaging, behavior, and session metadata accessed through the ONE API.
OpenNeuro
OpenNeuro is a free, open platform for sharing neuroimaging datasets, with public search, dataset pages, and download paths for web, S3, DataLad, and the OpenNeuro CLI.